A new ray of hope for uncomplicated falciparum malaria in India - A critical review
Abstract
No abstract
References
1. Switzerland. World Health Organization Global Malaria Program. World Malaria Report. 2011: 66.
2. India. Naional Institute of Malaria research and National Vector Borne disease Control Programme; Guidelines for Diagnosis and Treatment of Malaria in India. 2011: 1.
3. Nicholas J. White. Artemisinin based combination treatment of falciparum Malaria; American Society of Tropical Medicine and Hygiene. 2007; 77: 181–92.
4. Switzerland. World Health Organization; Guidelines for the treatment of malaria. Second edition; 2010:1.
5. Ridley RG. Medical need, Scientific opportunity and the drive for anti-malarial drugs. Nature. 2002; 415:686–93.
6. Shanks GD. Treatment of falciparum malaria in the age of drug resistance. Journal of Postgraduate Medical. 2006; 52:277–80.
7. Vennerstrom JL, Arbe-Barnes S, Brun R, et al. Identification of an anti-malarial synthetic trioxolane drug development candidate. Nature. 2004; 430:900–4.
8. Maerki S, Brun R, Charman SA, Dorn A, Matile H, Wittlin S. In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of plasmodium falciparum. Journal of Antimicrobial Chemotherapy. 2006;58:52-8.
9. Paliwal J. Pharmacokinetics of RBx 11160 in healthy subjects and P. falciparum patients. Abstract presented at: ASTMH 55th Annual Meeting; November 12-16, 2006; Atlanta, GA.
10. Biondi-Zoccai GG, Agostoni P, Abbate A, Testa L, Burzotta F. A simple hint to improve Robinson and- Dickersin’s highly sensitive PubMed search strategy for controlled clinical trials. International Journal of Epidemiology. 2005;34:224-5.
11. Gautam et al. Pharmacokinetics and Pharmacodynamics of Arterolane Maleate Following Multiple Oral Doses in Adult Patients with P. falciparum Malaria. Journal of Clinical Pharmacology. 2011;51:1519-28.
12. Valecha N. et al. Arterolane maleate and Piperaquine phosphate combination for the treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicentre randomized clinical trial. CID. 2010; 51:684-91.
13. Valecha N, et al. Arterolane maleate and Piperaquine phosphate combination for the treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicentre randomized clinical trial. CID. 2012; 55(5):663-71.
14. Giao PT, Binh TQ, Kager PA, et al. Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? Am J Trop Med Hyg. 2001; 65: 690-5.
15. Meshnick SR, Taylot TE, Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev. 1996; 60: 301-15.
16. McIntosh HM, Olliaro P. Artemisinin derivatives for treating severe malaria. Cochrane Database Syst Rev. 2000; 2: CD000527.
17. Price RN, Nosten F, Luxemberger C, et al. Effects of artemisinin derivatives on malarial transmissibility. Lancet. 1996; 347: 1654-8.
18. Falade C, Manyando C. Safety profile of Coartem: the evidence base. Malar J. 2009; 8 (suppl). Available at: http://www.malarialjournal.com/content/8/S1/S6. Accessed 20 June 2012.
2. India. Naional Institute of Malaria research and National Vector Borne disease Control Programme; Guidelines for Diagnosis and Treatment of Malaria in India. 2011: 1.
3. Nicholas J. White. Artemisinin based combination treatment of falciparum Malaria; American Society of Tropical Medicine and Hygiene. 2007; 77: 181–92.
4. Switzerland. World Health Organization; Guidelines for the treatment of malaria. Second edition; 2010:1.
5. Ridley RG. Medical need, Scientific opportunity and the drive for anti-malarial drugs. Nature. 2002; 415:686–93.
6. Shanks GD. Treatment of falciparum malaria in the age of drug resistance. Journal of Postgraduate Medical. 2006; 52:277–80.
7. Vennerstrom JL, Arbe-Barnes S, Brun R, et al. Identification of an anti-malarial synthetic trioxolane drug development candidate. Nature. 2004; 430:900–4.
8. Maerki S, Brun R, Charman SA, Dorn A, Matile H, Wittlin S. In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of plasmodium falciparum. Journal of Antimicrobial Chemotherapy. 2006;58:52-8.
9. Paliwal J. Pharmacokinetics of RBx 11160 in healthy subjects and P. falciparum patients. Abstract presented at: ASTMH 55th Annual Meeting; November 12-16, 2006; Atlanta, GA.
10. Biondi-Zoccai GG, Agostoni P, Abbate A, Testa L, Burzotta F. A simple hint to improve Robinson and- Dickersin’s highly sensitive PubMed search strategy for controlled clinical trials. International Journal of Epidemiology. 2005;34:224-5.
11. Gautam et al. Pharmacokinetics and Pharmacodynamics of Arterolane Maleate Following Multiple Oral Doses in Adult Patients with P. falciparum Malaria. Journal of Clinical Pharmacology. 2011;51:1519-28.
12. Valecha N. et al. Arterolane maleate and Piperaquine phosphate combination for the treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicentre randomized clinical trial. CID. 2010; 51:684-91.
13. Valecha N, et al. Arterolane maleate and Piperaquine phosphate combination for the treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicentre randomized clinical trial. CID. 2012; 55(5):663-71.
14. Giao PT, Binh TQ, Kager PA, et al. Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? Am J Trop Med Hyg. 2001; 65: 690-5.
15. Meshnick SR, Taylot TE, Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev. 1996; 60: 301-15.
16. McIntosh HM, Olliaro P. Artemisinin derivatives for treating severe malaria. Cochrane Database Syst Rev. 2000; 2: CD000527.
17. Price RN, Nosten F, Luxemberger C, et al. Effects of artemisinin derivatives on malarial transmissibility. Lancet. 1996; 347: 1654-8.
18. Falade C, Manyando C. Safety profile of Coartem: the evidence base. Malar J. 2009; 8 (suppl). Available at: http://www.malarialjournal.com/content/8/S1/S6. Accessed 20 June 2012.
Published
2019-09-09
How to Cite
Kavita Krishna, Panda B K, Dua P. (2019). A new ray of hope for uncomplicated falciparum malaria in India - A critical review. The Indian Practitioner, 67(8), 490-494. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/765
Section
Review article
